Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England ; volume:13 ; number:1 ; day:12 ; month:12 ; year:2022 ; pages:1-9 ; date:12.2022
Nature Communications ; 13, Heft 1 (12.12.2022), 1-9, 12.2022
- Urheber
-
Kirsebom, Freja Cordelia Møller
Andrews, Nick
Sachdeva, Ruchira
Stowe, Julia
Ramsay, Mary
Lopez Bernal, Jamie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-35168-7
- URN
-
urn:nbn:de:101:1-2023022121183580451153
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kirsebom, Freja Cordelia Møller
- Andrews, Nick
- Sachdeva, Ruchira
- Stowe, Julia
- Ramsay, Mary
- Lopez Bernal, Jamie
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine
Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine
Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine
Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants